Complement recruitment using bispecific diabodies

Nature Biotechnology

Volumn 15, Issue 7, 1997, Pages 629-631

  Kontermann, Roland E ^a,d   Wing, Mark G ^b,e   Winter, Greg ^a,c  

^a MRC CENTRE FOR PROTEIN ENGINEERING   (United Kingdom)

^b MRC Molecular Immunopathology Unit   (United Kingdom)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Antibody engineering; Complement Clq; Diabody; Phage display

Indexed keywords

BISPECIFIC ANTIBODY; COMPLEMENT COMPONENT C1Q; LYSOZYME; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HEMOLYSIS; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PHAGE DISPLAY; PHAGOCYTOSIS; PRIORITY JOURNAL; ROSETTE FORMATION; SHEEP ERYTHROCYTE;

ANIMALS; ANTIBODIES, BISPECIFIC; BASE SEQUENCE; BIOTECHNOLOGY; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; COMPLEMENT SYSTEM PROTEINS; ERYTHROCYTES; HEMOLYSIS; HUMANS; MONOCYTES; MURAMIDASE; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN ENGINEERING;

ANIMALIA; OVIS ARIES;

EID: 0030743802     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0797-629     Document Type: Article

References (30)

1. Winter, G., Griffiths, A.D., Hawkins, R.E., and Hoogenboom, H.R. 1994. Making antibodies by phage display technology. Anna Rev. Immunol. 12:433-455.
2. Duncan, A.R. and Winter, G. 1988. The binding site for C1q on IgG. Nature 332:738-740.
3. Duncan, AR., Woof, J.M., Partridge, L.J., Burton, D.R., and Winter, G. 1988. Localization of the binding site for the human high-affinity Fc receptor on IgG. Nature 332:563-564.
4. Burton, D.R. and Woof, J.M. 1992. Human antibody effector function. Adv. Immunol 51:1-84.
5. Fanger, M.W., Morganelli, RM., and Guyre, P.M. 1992. Bispecific antibodies. Crit. Rev. Immunol. 12:101-124.
6. Fanger, M.W. and Guyre, P.M. 1991. Bispecific antibodies for targeted cellular cytotoxicity. Trends Biotech. 9:375-380.
7. Holliger, P., Brissinck, J., Williams, R.L, Thielemans, K., and Winter, G. 1996, Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody. Protein Eng. 9:299-305.
8. Zhu, Z., Zapata, G., Shalaby, R., Snedecor, B., Chen, H., and Carter, P. 1996. High level secretion of a humanized bispecific diabody from Escherichia coli. Bio/Technology 14:192-196.
9. Cooper, N.R. 1985. The classical complement pathway: activation and regulation of the first complement component. Adv. Immunol. 37:151-216.
10. Erdei, A. and Reid, K.B.M. 1988. The C1q receptor. Mol. Immunol. 25:1067-1073.
11. Guan, E.N., Burgess, W.H., Robinson, S.L, Goodman, E.B., McTigue, K.J., and Tenner, A.J. 1991 Phagocytic cell molecules that bind the collagen-like region of C1 q. Involvement in the C1 q-mediated enhancement of phagocytosis. J. Biol. Cham. 266:20345-20355.
12. Holliger, P., Prospero, T.D., and Winter, G. 1993. “Diabodies”: small bivalent and bispecific antibody fragments. Proc. Natl. Acad. Sci. USA 90:6444-6448.
13. Perisic, O., Webb, P.A., Holliger, P., Winter, G., and Williams, R.L. 1994. Crystal structure of a diabody, a bivalent antibody fragment. Structure 2:1217-1226.
14. Kontermann, R.E., Martineau, P., Cummlngs, C.E., Karpas, A., Allen, D., Derbyshire, E., and Winter, G. 1997. Enzyme immunoassays using bispecific diabodies. Immunotechnology. In press.
15. Bobak, DA, Gaither, TG., Frank, M.M., and Tenner, A.J. 1987. Modulation of FcR function by complement subcomponent C1 q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. J. Immunol. 138:1150-1156.
16. Bobak, D.A., Washburn, R.G., and Frank, M.M. 1988. C1q enhances the phagocytosis of Cryptococcus neoformans blastospores by human monocytes. J. Immunol. 136:1023-1026.
17. Brown, E. J. 1991. Complement receptors and phagocytosis. Curr. Op. Immunol. 3:76-82.
18. Tenner, A.J. and Cooper, N.R. 1982. Stimulation of a human polymorphonuclear leukocyte oxidative response by the C1q subunit of the first complement component. J. Immunol. 128:2547-2552.
19. 2+ in mouse fibroblasts. J. Immunol. 141:3177-3185.
20. Xia, M.Q., Tone, M., Packman, L, Hake, G., and Waldmann, H. 1991. Characterization of the Campath-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone. Eur. J. Immunol. 21:1677-1684.
21. Holliger, P, Wing, M., Pound, J.D., Bohlen, H., and Winter, G. 1997. Retargeting serum immunoglobulin with bispecific antibodies. Nature Biotechnology 15:632-636.
22. Chatenoud, L, Ferran, C, Legendre, C, Thouard, I., Merite, S., Reuter, A., et al. 1990. In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids. Transplantation 49:697-702.
23. Moreau, T., Coles, A., Wing, M., Isaacs, J., Hale, G., Waldmann, H., and Compston, A. 1996. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 119:225-237.
24. Wing, M.G., Moreau, T., Greenwood, J., Smith, R.M., Hale, G., Isaacs, J., et al. 1996. Mechanism of first-dose cytokine-release syndrome by Campath-H: Involvement of CD16(FcgRIII)andCD11a/CD18(LFA-1)on NK cells. J. Clin. Invest. 98:2819-2826.
25. Wing, M.G., Waldmann, H., Isaacs, J., Compston, D.A.S., and Hale, G. 1997. Exvivo whole blood cultures for predicting cytokine release syndrome: dependence on target antigen and antibody isotype. Ther. Immunol. In press.
26. Alegre, M.L, Collins, A.M., Pulito, V.L, Brosius, R.A., Olson, W.C., Zivin, R.A., et al. 1992. Effect of a single amino acid mutation on the activating and immunosuppressive properties of a “humanized” OKT3 monoclonal antibody. J. Immunol. 148:3461-3468.
27. Alegre, M.L., Peterson, L.J., Xu, D., Sattar, H.A., Jeyarajah, D.R., Kowalkowski, K., et al. 1994. A non-activating “humanized” anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo. Transplantation 57:1537-1543.
28. Vaughan, T.J., Williams, A.J., Pritchard, K., Osbourn, J.K., Pope, A.R., Earnshaw, J.C., et al. 1996. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nature Biotechnology 14:309-314.
29. Marks, J.D., Hoogenboom, H.R., Bonnert, T.P., McCafferty, J., Griffiths, A.D., and Winter, G. 1991. By-passing immunisation: human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222:581-597.
30. McGuinness, B.T., Walter, G., FitzGerald, K., Schuler, P., Mahoney, W, Duncan, A.R., and Hoogenboom, H.R. 1996. Phage diabody repertoires for selection of large numbers of bispecific antibody fragments. Nature Biotechnology 14:1149-1154.